Miguel Coego Rios
Director of Finance/CFO at CENTOGENE N.V.
Miguel Coego Rios active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CENTOGENE N.V. | Director of Finance/CFO | 2022-03-30 | - |
| General Counsel | 2022-02-07 | - |
Career history of Miguel Coego Rios
Former positions of Miguel Coego Rios
| Companies | Position | Start | End |
|---|---|---|---|
| SHIRE | Corporate Officer/Principal | 2010-12-31 | 2018-12-31 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
| ORPHAZYME A/S | Corporate Officer/Principal | - | - |
Statistics
International
| Germany | 2 |
| Denmark | 2 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 1 |
| General Counsel | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| ORPHAZYME A/S | Health Technology |
| Private companies | 2 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Miguel Coego Rios
- Experience
